Endothelial progenitor cell number and ERK phosphorylation serve as predictive and prognostic biomarkers in advanced hepatocellular carcinoma patients treated with sorafenib

DOI: 10.1080/2162402X.2016.1226718

Keywords: Anti-VEGF therapy, biomarker, endothelial progenitor cells, ERK phosphorylation, hepatocellular carcinoma, sorafenib

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text